IC
SNDX icon

IEQ Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

IEQ Capital’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
54,835
-54,788
-50% -$1.14M 0.01% 1034
2026
Q1 		$2.56M Buy
109,623
+9,747
+10% +$212K 0.01% 678
2025
Q4 		$2.1M Buy
99,876
+44,672
+81% +$779K 0.01% 774
2025
Q3 		$849K Buy
55,204
+42,044
+319% +$550K ﹤0.01% 1072
2025
Q2 		$123K Sell
13,160
-46,050
-78% -$507K ﹤0.01% 1692
2025
Q1 		$727K Buy
+59,210
New +$835K 0.01% 843

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

IEQ Capital's SNDX Position: Q2 2026 in Review

IEQ Capital reduced its Syndax Pharmaceuticals (SNDX) stake by 50% in Q2 2026, selling an estimated $1.14M and leaving 54,835 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1034.

IEQ Capital first reported a position in SNDX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.56M in Q1 2026. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • IEQ Capital held 54,835 shares of Syndax Pharmaceuticals worth $1.2M as of Q2 2026.
  • IEQ Capital sold 54,788 Syndax Pharmaceuticals shares in Q2 2026, an estimated $1.14M.
  • Syndax Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #1034 holding.
  • IEQ Capital first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Syndax Pharmaceuticals position peaked at $2.56M in Q1 2026.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.